10/19/2026
AI can support clinical trial decisions. But who is accountable when something goes wrong?
As AI becomes increasingly integrated into clinical research, questions around validation, human oversight, risk management, and accountability are more important than ever.
We asked Joris De Maeseneire, Head of Quality at Cromos Pharma, six key questions about AI governance, evolving FDA and EMA expectations, and what it takes to ensure responsible AI use in clinical trials.
The key takeaway? You can delegate the task. You cannot delegate the accountability.
Read the full interview: https://cromospharma.com/ai-quality-and-accountability-six-questions-every-quality-leader-should-ask/